Searched over 200M research papers
10 papers analyzed
Some studies suggest caffeine can raise blood pressure, especially in certain individuals and under specific conditions, while other studies indicate that long-term or habitual consumption does not significantly increase cardiovascular risk.
20 papers analyzed
Caffeine intake has been shown to cause an immediate increase in blood pressure (BP). In a study involving hypertensive subjects, a single dose of 250 mg of caffeine resulted in a significant rise in systolic blood pressure (SBP) by 9.2 mm Hg within 15 minutes. Similarly, a meta-analysis found that 200-300 mg of caffeine increased SBP by an average of 8.1 mm Hg and diastolic blood pressure (DBP) by 5.7 mm Hg, with effects lasting for at least three hours. These findings are consistent across various studies, indicating that caffeine can acutely elevate BP, particularly in individuals with hypertension .
The vasoconstrictive effects of caffeine are more pronounced in individuals with borderline hypertension. In a study of men with borderline hypertension, caffeine-induced changes in DBP were significantly larger compared to normotensive controls, suggesting greater systemic vascular resistance. This enhanced response could potentially stabilize high resistance states, thereby facilitating disease progression in susceptible individuals.
While acute caffeine intake raises BP, the long-term effects are less clear. Some studies suggest that regular caffeine consumption may lead to tolerance, reducing its pressor effects over time. For instance, a systematic review found no significant increase in BP after two weeks of regular coffee consumption compared to a caffeine-free diet. This indicates that the body may adapt to the regular intake of caffeine, mitigating its impact on BP in the long term .
A meta-analysis of randomized controlled trials revealed a modest but significant rise in BP with chronic caffeine intake. The pooled data showed an increase of 2.04 mm Hg in SBP and 0.73 mm Hg in DBP. However, the BP elevations were more substantial with pure caffeine compared to coffee, suggesting that other components in coffee might modulate caffeine's hypertensive effects.
Despite the acute BP elevations, habitual coffee consumption does not appear to be associated with an increased risk of cardiovascular disease (CVD) in hypertensive individuals. A systematic review and meta-analysis of cohort studies found no evidence linking regular coffee consumption with a higher risk of CVD. This suggests that while caffeine can acutely raise BP, it may not necessarily translate into long-term cardiovascular harm.
Genetic variations, particularly in the CYP1A2 gene, which affects caffeine metabolism, can influence the relationship between caffeine intake and BP. Non-smokers with certain CYP1A2 variants who consume higher amounts of caffeine tend to have lower BP and reduced odds of hypertension. This highlights the role of genetic factors in modulating the cardiovascular effects of caffeine.
Caffeine intake can acutely elevate BP, especially in hypertensive individuals, due to its vasoconstrictive properties. However, regular consumption may lead to tolerance, reducing its long-term impact on BP. While acute BP elevations are well-documented, there is no clear evidence linking habitual coffee consumption with increased CVD risk. Genetic factors also play a significant role in individual responses to caffeine. Future research should focus on standardizing methodologies to better understand the complex relationship between caffeine, BP, and cardiovascular health.
Most relevant research papers on this topic